Matches in Wikidata for { <http://www.wikidata.org/entity/Q89241553> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q89241553 description "article scientifique publié en 2014" @default.
- Q89241553 description "artículu científicu espublizáu n'ochobre de 2014" @default.
- Q89241553 description "im Oktober 2014 veröffentlichter wissenschaftlicher Artikel" @default.
- Q89241553 description "scientific article published on 26 October 2014" @default.
- Q89241553 description "wetenschappelijk artikel" @default.
- Q89241553 description "наукова стаття, опублікована в жовтні 2014" @default.
- Q89241553 name "Disappearance of B-Symptoms In Comorbid Patients Receiving First-Line Obinutuzumab (Ga101) -Chlorambucil (G-Clb) Or Rituximab-Chlorambucil (R-Clb) for Chronic Lymphocytic Leukemia (Cll)" @default.
- Q89241553 name "Disappearance of B-Symptoms In Comorbid Patients Receiving First-Line Obinutuzumab (Ga101) -Chlorambucil (G-Clb) Or Rituximab-Chlorambucil (R-Clb) for Chronic Lymphocytic Leukemia (Cll)" @default.
- Q89241553 type Item @default.
- Q89241553 label "Disappearance of B-Symptoms In Comorbid Patients Receiving First-Line Obinutuzumab (Ga101) -Chlorambucil (G-Clb) Or Rituximab-Chlorambucil (R-Clb) for Chronic Lymphocytic Leukemia (Cll)" @default.
- Q89241553 label "Disappearance of B-Symptoms In Comorbid Patients Receiving First-Line Obinutuzumab (Ga101) -Chlorambucil (G-Clb) Or Rituximab-Chlorambucil (R-Clb) for Chronic Lymphocytic Leukemia (Cll)" @default.
- Q89241553 prefLabel "Disappearance of B-Symptoms In Comorbid Patients Receiving First-Line Obinutuzumab (Ga101) -Chlorambucil (G-Clb) Or Rituximab-Chlorambucil (R-Clb) for Chronic Lymphocytic Leukemia (Cll)" @default.
- Q89241553 prefLabel "Disappearance of B-Symptoms In Comorbid Patients Receiving First-Line Obinutuzumab (Ga101) -Chlorambucil (G-Clb) Or Rituximab-Chlorambucil (R-Clb) for Chronic Lymphocytic Leukemia (Cll)" @default.
- Q89241553 P1433 Q89241553-800AE81D-B20E-4EAE-BC33-DC5AFF42264E @default.
- Q89241553 P1476 Q89241553-816FBDDF-873E-4410-A64B-AC0FE0F58341 @default.
- Q89241553 P2093 Q89241553-09C2CE9D-6BF2-46ED-A0FA-6635E48C2E4A @default.
- Q89241553 P2093 Q89241553-4E61EDD2-3DA8-496E-AA11-1F098F21278E @default.
- Q89241553 P2093 Q89241553-5A649342-064B-484C-86D3-3358C1853FBD @default.
- Q89241553 P2093 Q89241553-6D9134D7-5F49-46B2-95FB-DC72CDCABDDC @default.
- Q89241553 P2093 Q89241553-DAD858E3-6D57-44EC-968B-427B194576C3 @default.
- Q89241553 P304 Q89241553-70E717BE-BA5F-4C45-A7F6-D2F40CC88208 @default.
- Q89241553 P31 Q89241553-263ACD12-8301-47E1-87CF-F78D58DCFE70 @default.
- Q89241553 P356 Q89241553-AB69D491-E701-4BC6-A5AF-EEFBDF98B058 @default.
- Q89241553 P433 Q89241553-E4B475E7-9FDA-419D-AAA1-036D7C9ACEA7 @default.
- Q89241553 P478 Q89241553-84599E53-57E4-4942-8287-6CC5F1DA4BF3 @default.
- Q89241553 P577 Q89241553-16F4C7B1-5BF3-4C46-B141-7CC8D9A43F19 @default.
- Q89241553 P698 Q89241553-007F0D8E-1C6F-4788-9795-373E8D81B319 @default.
- Q89241553 P921 Q89241553-DF5ED75E-5A70-4549-8804-AA8244C169CD @default.
- Q89241553 P356 J.JVAL.2014.08.1636 @default.
- Q89241553 P698 27201638 @default.
- Q89241553 P1433 Q15766908 @default.
- Q89241553 P1476 "Disappearance of B-Symptoms In Comorbid Patients Receiving First-Line Obinutuzumab (Ga101) -Chlorambucil (G-Clb) Or Rituximab-Chlorambucil (R-Clb) for Chronic Lymphocytic Leukemia (Cll)" @default.
- Q89241553 P2093 "A Bernhardt" @default.
- Q89241553 P2093 "Andres S Wenk" @default.
- Q89241553 P2093 "C Wiesner" @default.
- Q89241553 P2093 "S Klawitter" @default.
- Q89241553 P2093 "U Becker" @default.
- Q89241553 P304 "A522" @default.
- Q89241553 P31 Q13442814 @default.
- Q89241553 P356 "10.1016/J.JVAL.2014.08.1636" @default.
- Q89241553 P433 "7" @default.
- Q89241553 P478 "17" @default.
- Q89241553 P577 "2014-10-26T00:00:00Z" @default.
- Q89241553 P698 "27201638" @default.
- Q89241553 P921 Q1088156 @default.